Panbela Therapeutics Inc.
NASDAQ:PBLA 4:00:00 PM EDT
Search For a Symbol
Panbela Therapeutics Inc. Stock, NASDAQ:PBLA
712 Vista Boulevard, Suite 305, Waconia, Minnesota 55387
United States of America
Number of Employees: 7
Panbela Therapeutics, Inc. engages in the development of disruptive therapeutics for medical purposes. It focuses on development programs that target diseases of the pancreas, including pancreatic cancer and pancreatitis. The firmÃ¢â?¬â?¢s product candidate, SBP-101, is a proprietary polyamine analogue designed to induce polyamine metabolic inhibition (PMI), a metabolic pathway of critical importance in multiple tumor types. The company was founded by Michael T. Cullen, Jr. and Thomas X. Neenan on September 21, 2011 and is headquartered in Waconia, MN.